![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 14, 14302-14309, April 8, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
II Alternative Splicing via Phosphorylation of Serine/Arginine-rich Splicing Factor SRp40*






||**
From the
Departments of Biochemistry and Molecular Biology and Internal Medicine and the
Department of Pathology, University of South Florida College of Medicine, Tampa, Florida 33612, the ||J. A. Haley Veterans Hospital, Tampa, Florida 33612, and the ¶Howard Hughes Medical Institute, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
Insulin regulates alternative splicing of PKC
II mRNA by phosphorylation of SRp40 via a phosphatidylinositol 3-kinase pathway (Patel, N. A., Chalfant, C. E., Watson, J. E., Wyatt, J. R., Dean, N. M., Eichler, D. C., and Cooper, D. C. (2001) J. Biol. Chem. 276, 2264822654). Transient transfection of constitutively active Akt2 kinase promotes PKC
II exon inclusion. Serine/arginine-rich (SR) RNA-binding proteins regulating the selection of alternatively spliced exons are potential substrates of Akt kinase because many of them contain RXRXX(S/T) motifs. Here we show that Akt2 kinase phosphorylated SRp40 in vivo and in vitro. Mutation of Ser86 on SRp40 blocked in vitro phosphorylation. In control Akt2(+/+) fibroblasts, insulin treatment increased the phosphorylation of endogenous SR proteins, but their phosphorylation state remained unaltered by insulin in fibroblasts from Akt2(-/-) mice. Levels of PKC
II protein were up-regulated by insulin in Akt2(+/+) cells; however, only very low levels of PKC
II were detected in Akt2(-/-) cells and did not change following insulin treatment. Endogenous PKC
I and -
II mRNA levels in Akt2(+/+) and Akt2(-/-) gastrocnemius muscle tissues were compared using quantitative real time PCR. The results indicated a 54% decrease in the expression of PKC
II levels in Akt(-/-), whereas PKC
I levels remained unchanged in both samples. Further, transfection of Akt2(-/-) cells with a PKC
II splicing minigene revealed defective
II exon inclusion. Co-transfection of the mutated SRp40 attenuated
II exon inclusion. This study provides in vitro and in vivo evidence showing Akt2 kinase directly phosphorylated SRp40, thereby connecting the insulin, PI 3-kinase/Akt pathway with phosphorylation of a site on a nuclear splicing protein promoting exon inclusion. This model is upheld in Akt2-deficient mice with insulin resistance leading to diabetes mellitus.
Received for publication, October 8, 2004 , and in revised form, January 24, 2005.
* This work was supported by NIDDK, National Institutes of Health Grant 54393 (to D. R. C.), the Department of Veterans Affairs Medical Research Service (to D. R. C.), National Institutes of Health Grant DK39615 (to M. J. B.), and National Institutes of Health Grant CA077935 (to J. Q. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed: Research Service 151, J. A. Haley Veterans Hospital, 13000 Bruce B. Downs Blvd., Tampa, FL 33612. Tel.: 813-972-2000, Ext. 7017; Fax: 813-978-5889; E-mail: dcooper{at}hsc.usf.edu.
This article has been cited by other articles:
![]() |
S. Stamm Regulation of Alternative Splicing by Reversible Protein Phosphorylation J. Biol. Chem., January 18, 2008; 283(3): 1223 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Revil, J. Toutant, L. Shkreta, D. Garneau, P. Cloutier, and B. Chabot Protein Kinase C-Dependent Control of Bcl-x Alternative Splicing Mol. Cell. Biol., December 15, 2007; 27(24): 8431 - 8441. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Melton, J. Jackson, J. Wang, and K. W. Lynch Combinatorial Control of Signal-Induced Exon Repression by hnRNP L and PSF Mol. Cell. Biol., October 1, 2007; 27(19): 6972 - 6984. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ghosh, N. Patel, K. Jiang, J. E. Watson, J. Cheng, C. E. Chalfant, and D. R. Cooper Ceramide-Activated Protein Phosphatase Involvement in Insulin Resistance via Akt, Serine/Arginine-Rich Protein 40, and Ribonucleic Acid Splicing in L6 Skeletal Muscle Cells Endocrinology, March 1, 2007; 148(3): 1359 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Szeszel-Fedorowicz, I. Talukdar, B. N. Griffith, C. M. Walsh, and L. M. Salati An Exonic Splicing Silencer Is Involved in the Regulated Splicing of Glucose 6-Phosphate Dehydrogenase mRNA J. Biol. Chem., November 10, 2006; 281(45): 34146 - 34158. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Srebrow and A. R. Kornblihtt The connection between splicing and cancer J. Cell Sci., July 1, 2006; 119(13): 2635 - 2641. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Newman, S. J. Muh, R. H. Hovhannisyan, C. C. Warzecha, R. B. Jones, W. L. McKeehan, and R. P. Carstens Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays RNA, June 1, 2006; 12(6): 1129 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Talukdar, W. Szeszel-Fedorowicz, and L. M. Salati Arachidonic Acid Inhibits the Insulin Induction of Glucose-6-phosphate Dehydrogenase via p38 MAP Kinase J. Biol. Chem., December 9, 2005; 280(49): 40660 - 40667. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. A. Coelho, B. Kolevski, C. D. Walker, I. Lavagi, T. Shaw, A. Ebert, S. J. Leevers, and S. J. Marygold A Genetic Screen for Dominant Modifiers of a Small-Wing Phenotype in Drosophila melanogaster Identifies Proteins Involved in Splicing and Translation Genetics, October 1, 2005; 171(2): 597 - 614. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |